Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229–63.
Wang J, Yang J, Narang A, He J, Wolfgang C, Li K, et al. Consensus, debate, and prospective on pancreatic cancer treatments. J Hematol Oncol. 2024;17(1):92.
Article PubMed PubMed Central Google Scholar
D’Angelo FA, Antolino L, La Rocca M, Petrucciani N, Magistri P, Aurello P, et al. Adjuvant and neoadjuvant therapies in resectable pancreatic cancer: a systematic review of randomized controlled trials. Med Oncol. 2016;33(3):28.
Jurcak N, Zheng L. Signaling in the microenvironment of pancreatic cancer: transmitting along the nerve. Pharmacol Ther. 2019;200:126–34.
Article CAS PubMed PubMed Central Google Scholar
Hu J, Chen W, Shen L, Chen Z, Huang J. Crosstalk between the peripheral nervous system and breast cancer influences tumor progression. Biochim Biophys Acta Rev Cancer. 2022;1877(6):188828.
Article CAS PubMed Google Scholar
Yin L, Li J, Wang J, Pu T, Wei J, Li Q, et al. MAOA promotes prostate cancer cell perineural invasion through SEMA3C/PlexinA2/NRP1-cMET signaling. Oncogene. 2021;40(7):1362–74.
Article CAS PubMed PubMed Central Google Scholar
Dawson H, Bokhorst JM, Studer L, Vieth M, Oguz Erdogan AS, Kus Öztürk S, et al. Lymph node metastases and recurrence in pT1 colorectal cancer: prediction with the International Budding Consortium Score-A retrospective, multi-centric study. United Eur Gastroenterol J. 2024;12(3):299–308.
Wang J, Li Q, Liang F, Du X, Song P, Wu T, et al. Dickkopf-1 drives perineural invasion via PI3K-AKT signaling pathway in head and neck squamous cancer. MedComm. 2024;5(4):e518.
Article CAS PubMed PubMed Central Google Scholar
Schorn S, Demir IE, Haller B, Scheufele F, Reyes CM, Tieftrunk E, et al. The influence of neural invasion on survival and tumor recurrence in pancreatic ductal adenocarcinoma—a systematic review and meta-analysis. Surg Oncol. 2017;26(1):105–15.
Liebig C, Ayala G, Wilks JA, Berger DH, Albo D. Perineural invasion in cancer: a review of the literature. Cancer. 2009;115(15):3379–91.
Article CAS PubMed Google Scholar
Crippa S, Pergolini I, Javed AA, Honselmann KC, Weiss MJ, Di Salvo F, et al. Implications of perineural invasion on disease recurrence and survival after pancreatectomy for pancreatic head ductal adenocarcinoma. Ann Surg. 2022;276(2):378–85.
Han X, Hu X, Zhao J, Ma J, Jemal A, Yabroff KR. Trends of cancer-related suicide in the United States: 1999–2018. J Natl Cancer Inst. 2021;113(9):1258–62.
Zhang Z, Lv ZG, Lu M, Li H, Zhou J. Nerve-tumor crosstalk in tumor microenvironment: from tumor initiation and progression to clinical implications. Biochim Biophys Acta Rev Cancer. 2024;1879(4):189121.
Article CAS PubMed Google Scholar
Corona A, Blobe GC. The role of the extracellular matrix protein TGFBI in cancer. Cell Signal. 2021;84:110028.
Article CAS PubMed Google Scholar
Huang H, Tang Q, Li S, Qin Y, Zhu G. TGFBI: a novel therapeutic target for cancer. Int Immunopharmacol. 2024;134:112180.
Article CAS PubMed Google Scholar
Qin T, Li J, Xiao Y, Wang X, Gong M, Wang Q, et al. Honokiol suppresses perineural invasion of pancreatic cancer by inhibiting SMAD2/3 signaling. Front Oncol. 2021;11:728583.
Article CAS PubMed PubMed Central Google Scholar
Li W, Jiang Z, Xiao X, Wang Z, Wu Z, Ma Q, et al. Curcumin inhibits superoxide dismutase-induced epithelial-to-mesenchymal transition via the PI3K/Akt/NF-κB pathway in pancreatic cancer cells. Int J Oncol. 2018;52(5):1593–602.
Jiang SH, Zhang S, Wang H, Xue JL, Zhang ZG. Emerging experimental models for assessing perineural invasion in human cancers. Cancer Lett. 2022;535:215610.
Article CAS PubMed Google Scholar
Bakst RL, Xiong H, Chen CH, Deborde S, Lyubchik A, Zhou Y, et al. Inflammatory monocytes promote perineural invasion via CCL2-mediated recruitment and cathepsin B expression. Can Res. 2017;77(22):6400–14.
Zhang J-F, Tao L-Y, Yang M-W, Xu D-P, Jiang S-H, Fu X-L, et al. CD74 promotes perineural invasion of cancer cells and mediates neuroplasticity via the AKT/EGR-1/GDNF axis in pancreatic ductal adenocarcinoma. Cancer Lett. 2021;508:47–58.
Article CAS PubMed Google Scholar
Alrawashdeh W, Jones R, Dumartin L, Radon TP, Cutillas PR, Feakins RM, et al. Perineural invasion in pancreatic cancer: proteomic analysis and in vitro modelling. Mol Oncol. 2019;13(5):1075–91.
Article CAS PubMed PubMed Central Google Scholar
Zhan S, Bai X, Zhao Y, Tuoheti K, Yisha Z, Zuo Y, et al. TGFBI promotes proliferation and epithelial-mesenchymal transition in renal cell carcinoma through PI3K/AKT/mTOR/HIF-1α pathway. Cancer Cell Int. 2024;24(1):265.
Article CAS PubMed PubMed Central Google Scholar
Peng D, Fu M, Wang M, Wei Y, Wei X. Targeting TGF-β signal transduction for fibrosis and cancer therapy. Mol Cancer. 2022;21(1):104.
Article CAS PubMed PubMed Central Google Scholar
Sarubo M, Mouri Y, Moromizato A, Yamada A, Jin S, Shao W, et al. Involvement of TGFBI-TAGLN axis in cancer stem cell property of head and neck squamous cell carcinoma. Sci Rep. 2024;14(1):6767.
Article CAS PubMed PubMed Central Google Scholar
Al Shareef Z, Kardooni H, Murillo-Garzón V, Domenici G, Stylianakis E, Steel JH, et al. Protective effect of stromal Dickkopf-3 in prostate cancer: opposing roles for TGFBI and ECM-1. Oncogene. 2018;37(39):5305–24.
Article CAS PubMed PubMed Central Google Scholar
Zou J, Huang R, Li H, Wang B, Chen Y, Chen S, et al. Secreted TGF-beta-induced protein promotes aggressive progression in bladder cancer cells. Cancer Manag Res. 2019;11:6995–7006.
Article CAS PubMed PubMed Central Google Scholar
Costanza B, Rademaker G, Tiamiou A, De Tullio P, Leenders J, Blomme A, et al. Transforming growth factor beta-induced, an extracellular matrix interacting protein, enhances glycolysis and promotes pancreatic cancer cell migration. Int J Cancer. 2019;145(6):1570–84.
Article CAS PubMed Google Scholar
Sato T, Muramatsu T, Tanabe M, Inazawa J. Identification and characterization of transforming growth factor beta-induced in circulating tumor cell subline from pancreatic cancer cell line. Cancer Sci. 2018;109(11):3623–33.
Article CAS PubMed PubMed Central Google Scholar
Wang H, Xu YH, Guo Y. Novel prognostic marker TGFBI affects the migration and invasion function of ovarian cancer cells and activates the integrin αvβ3-PI3K-Akt signaling pathway. J Ovarian Res. 2024;17(1):50.
Article CAS PubMed PubMed Central Google Scholar
Ma S, Wang J, Cui Z, Yang X, Cui X, Li X, et al. HIF-2α-dependent TGFBI promotes ovarian cancer chemoresistance by activating PI3K/Akt pathway to inhibit apoptosis and facilitate DNA repair process. Sci Rep. 2024;14(1):3870.
Comments (0)